Coronavirus Test Kits Market in Europe 2023-2027

PUBLISHED: October 5, 2023

PAGES: 147 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The test kits market in Europe is forecasted to grow by USD -17.29 bn during 2022-2027, decelerating at a CAGR of -23.8% during the forecast period. The report on the test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing government funding, rising focus on preventing the spread of COVID-19 pandemic, and increasing number of strategic alliances.

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	-14.83%
CAGR	-23.8%
Incremental Value	$-17.29bn

Technavio's test kits market in Europe is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

This study identifies the advent of SARS-CoV-2 mutation as one of the prime reasons driving the test kits market in Europe growth during the next few years. Also, increasing demand for point-of-care diagnostics and rising adoption of rapid diagnostic products will lead to sizable demand in the market.

The report on the test kits market in Europe covers the following areas:

Test kits market in Europe sizing
Test kits market in Europe forecast
Test kits market in Europe industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc., Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, PerkinElmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED. Also, the test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43247

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary €" Chart on Market Overview
Exhibit 02: Executive Summary €" Data Table on Market Overview
Exhibit 03: Executive Summary €" Chart on Country Market Characteristics
Exhibit 04: Executive Summary €" Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €" Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary €" Chart on Market Segmentation by Type
Exhibit 07: Executive Summary €" Chart on Incremental Growth
Exhibit 08: Executive Summary €" Data Table on Incremental Growth
Exhibit 09: Executive Summary €" Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers €" Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers €" Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants €" Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes €" Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry €" Impact of key factors in 2022 and 2027
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
5.2 Comparison by End-user
Exhibit 27: Chart on Comparison by End-user
Exhibit 28: Data Table on Comparison by End-user
5.3 Government - Market size and forecast 2022-2027
Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
5.4 Non-government - Market size and forecast 2022-2027
Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
5.5 Market opportunity by End-user
Exhibit 37: Market opportunity by End-user ($ billion)
Exhibit 38: Data Table on Market opportunity by End-user ($ billion)

6 Market Segmentation by Type

6.1 Market segments
Exhibit 39: Chart on Type - Market share 2022-2027 (%)
Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 41: Chart on Comparison by Type
Exhibit 42: Data Table on Comparison by Type
6.3 Rapid test kit - Market size and forecast 2022-2027
Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
6.4 RT-PCR - Market size and forecast 2022-2027
Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ billion)
Exhibit 56: Data Table on Market opportunity by Type ($ billion)

7 Customer Landscape

7.1 Customer landscape overview
Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
8.2 Geographic comparison
Exhibit 60: Chart on Geographic comparison
Exhibit 61: Data Table on Geographic comparison
8.3 UK - Market size and forecast 2022-2027
Exhibit 62: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 63: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on UK - Year-over-year growth 2022-2027 (%)
8.4 Spain - Market size and forecast 2022-2027
Exhibit 66: Chart on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Spain - Year-over-year growth 2022-2027 (%)
8.5 Russia - Market size and forecast 2022-2027
Exhibit 70: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibit 73: Data Table on Russia - Year-over-year growth 2022-2027 (%)
8.6 France - Market size and forecast 2022-2027
Exhibit 74: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2022-2027 (%)
8.7 Rest of Europe - Market size and forecast 2022-2027
Exhibit 78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibit 81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
8.8 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ billion)
Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Trends

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 84: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends

10 Vendor Landscape

10.1 Overview
10.2 Vendor landscape
Exhibit 85: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 86: Overview on factors of disruption
10.4 Industry risks
Exhibit 87: Impact of key risks on business

11 Vendor Analysis

11.1 Vendors covered
Exhibit 88: Vendors covered
11.2 Market positioning of vendors
Exhibit 89: Matrix on vendor position and classification
11.3 3D Biomedicine Science and Technology Co. Ltd.
Exhibit 90: 3D Biomedicine Science and Technology Co. Ltd. - Overview
Exhibit 91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
Exhibit 92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
11.4 Abbott Laboratories
Exhibit 93: Abbott Laboratories - Overview
Exhibit 94: Abbott Laboratories - Business segments
Exhibit 95: Abbott Laboratories - Key news
Exhibit 96: Abbott Laboratories - Key offerings
Exhibit 97: Abbott Laboratories - Segment focus
11.5 altona Diagnostics GmbH
Exhibit 98: altona Diagnostics GmbH - Overview
Exhibit 99: altona Diagnostics GmbH - Product / Service
Exhibit 100: altona Diagnostics GmbH - Key offerings
11.6 BGI Genomics Co. Ltd.
Exhibit 101: BGI Genomics Co. Ltd. - Overview
Exhibit 102: BGI Genomics Co. Ltd. - Product / Service
Exhibit 103: BGI Genomics Co. Ltd. - Key offerings
11.7 Bio Rad Laboratories Inc.
Exhibit 104: Bio Rad Laboratories Inc. - Overview
Exhibit 105: Bio Rad Laboratories Inc. - Business segments
Exhibit 106: Bio Rad Laboratories Inc. - Key news
Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
11.8 bioMerieux SA
Exhibit 109: bioMerieux SA - Overview
Exhibit 110: bioMerieux SA - Product / Service
Exhibit 111: bioMerieux SA - Key offerings
11.9 BIOSYNEX SA
Exhibit 112: BIOSYNEX SA - Overview
Exhibit 113: BIOSYNEX SA - Product / Service
Exhibit 114: BIOSYNEX SA - Key offerings
11.10 Bruker Corp.
Exhibit 115: Bruker Corp. - Overview
Exhibit 116: Bruker Corp. - Business segments
Exhibit 117: Bruker Corp. - Key news
Exhibit 118: Bruker Corp. - Key offerings
Exhibit 119: Bruker Corp. - Segment focus
11.11 Co Diagnostics Inc.
Exhibit 120: Co Diagnostics Inc. - Overview
Exhibit 121: Co Diagnostics Inc. - Product / Service
Exhibit 122: Co Diagnostics Inc. - Key news
Exhibit 123: Co Diagnostics Inc. - Key offerings
11.12 Danaher Corp.
Exhibit 124: Danaher Corp. - Overview
Exhibit 125: Danaher Corp. - Business segments
Exhibit 126: Danaher Corp. - Key news
Exhibit 127: Danaher Corp. - Key offerings
Exhibit 128: Danaher Corp. - Segment focus
11.13 Edinburgh Genetics Ltd.
Exhibit 129: Edinburgh Genetics Ltd. - Overview
Exhibit 130: Edinburgh Genetics Ltd. - Product / Service
Exhibit 131: Edinburgh Genetics Ltd. - Key offerings
11.14 F. Hoffmann La Roche Ltd.
Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
11.15 QIAGEN NV
Exhibit 137: QIAGEN NV - Overview
Exhibit 138: QIAGEN NV - Product / Service
Exhibit 139: QIAGEN NV - Key news
Exhibit 140: QIAGEN NV - Key offerings
11.16 Thermo Fisher Scientific Inc.
Exhibit 141: Thermo Fisher Scientific Inc. - Overview
Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
Exhibit 143: Thermo Fisher Scientific Inc. - Key news
Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
11.17 ZEKMED
Exhibit 146: ZEKMED - Overview
Exhibit 147: ZEKMED - Product / Service
Exhibit 148: ZEKMED - Key offerings

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 149: Inclusions checklist
Exhibit 150: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 151: Currency conversion rates for US$
12.4 Research methodology
Exhibit 152: Research methodology
Exhibit 153: Validation techniques employed for market sizing
Exhibit 154: Information sources
12.5 List of abbreviations
Exhibit 155: List of abbreviations
- generated by emerging segments in healthcare: Growing adoption of healthcare supplies for home-based healthcare, home medical devices, and other advanced application areas such as robotic surgery will aid in the growth of this market.

Product Code: IRTNTR43247

Exhibits:

Exhibits1: Executive Summary €" Chart on Market Overview
Exhibits2: Executive Summary €" Data Table on Market Overview
Exhibits3: Executive Summary €" Chart on Country Market Characteristics
Exhibits4: Executive Summary €" Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €" Chart on Market Segmentation by End-user
Exhibits6: Executive Summary €" Chart on Market Segmentation by Type
Exhibits7: Executive Summary €" Chart on Incremental Growth
Exhibits8: Executive Summary €" Data Table on Incremental Growth
Exhibits9: Executive Summary €" Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits18: Five forces analysis - Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers €" Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers €" Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants €" Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes €" Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry €" Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition - Five forces 2022 and 2027
Exhibits25: Chart on End-user - Market share 2022-2027 (%)
Exhibits26: Data Table on End-user - Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by End-user
Exhibits28: Data Table on Comparison by End-user
Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits37: Market opportunity by End-user ($ billion)
Exhibits38: Data Table on Market opportunity by End-user ($ billion)
Exhibits39: Chart on Type - Market share 2022-2027 (%)
Exhibits40: Data Table on Type - Market share 2022-2027 (%)
Exhibits41: Chart on Comparison by Type
Exhibits42: Data Table on Comparison by Type
Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ billion)
Exhibits56: Data Table on Market opportunity by Type ($ billion)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Spain - Year-over-year growth 2022-2027 (%)
Exhibits70: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibits73: Data Table on Russia - Year-over-year growth 2022-2027 (%)
Exhibits74: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits77: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ billion)
Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ billion)
Exhibits84: Impact of drivers and challenges in 2022 and 2027
Exhibits85: Overview on Criticality of inputs and Factors of differentiation
Exhibits86: Overview on factors of disruption
Exhibits87: Impact of key risks on business
Exhibits88: Vendors covered
Exhibits89: Matrix on vendor position and classification
Exhibits90: 3D Biomedicine Science and Technology Co. Ltd. - Overview
Exhibits91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
Exhibits92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
Exhibits93: Abbott Laboratories - Overview
Exhibits94: Abbott Laboratories - Business segments
Exhibits95: Abbott Laboratories - Key news
Exhibits96: Abbott Laboratories - Key offerings
Exhibits97: Abbott Laboratories - Segment focus
Exhibits98: altona Diagnostics GmbH - Overview
Exhibits99: altona Diagnostics GmbH - Product / Service
Exhibits100: altona Diagnostics GmbH - Key offerings
Exhibits101: BGI Genomics Co. Ltd. - Overview
Exhibits102: BGI Genomics Co. Ltd. - Product / Service
Exhibits103: BGI Genomics Co. Ltd. - Key offerings
Exhibits104: Bio Rad Laboratories Inc. - Overview
Exhibits105: Bio Rad Laboratories Inc. - Business segments
Exhibits106: Bio Rad Laboratories Inc. - Key news
Exhibits107: Bio Rad Laboratories Inc. - Key offerings
Exhibits108: Bio Rad Laboratories Inc. - Segment focus
Exhibits109: bioMerieux SA - Overview
Exhibits110: bioMerieux SA - Product / Service
Exhibits111: bioMerieux SA - Key offerings
Exhibits112: BIOSYNEX SA - Overview
Exhibits113: BIOSYNEX SA - Product / Service
Exhibits114: BIOSYNEX SA - Key offerings
Exhibits115: Bruker Corp. - Overview
Exhibits116: Bruker Corp. - Business segments
Exhibits117: Bruker Corp. - Key news
Exhibits118: Bruker Corp. - Key offerings
Exhibits119: Bruker Corp. - Segment focus
Exhibits120: Co Diagnostics Inc. - Overview
Exhibits121: Co Diagnostics Inc. - Product / Service
Exhibits122: Co Diagnostics Inc. - Key news
Exhibits123: Co Diagnostics Inc. - Key offerings
Exhibits124: Danaher Corp. - Overview
Exhibits125: Danaher Corp. - Business segments
Exhibits126: Danaher Corp. - Key news
Exhibits127: Danaher Corp. - Key offerings
Exhibits128: Danaher Corp. - Segment focus
Exhibits129: Edinburgh Genetics Ltd. - Overview
Exhibits130: Edinburgh Genetics Ltd. - Product / Service
Exhibits131: Edinburgh Genetics Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Overview
Exhibits133: F. Hoffmann La Roche Ltd. - Business segments
Exhibits134: F. Hoffmann La Roche Ltd. - Key news
Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits137: QIAGEN NV - Overview
Exhibits138: QIAGEN NV - Product / Service
Exhibits139: QIAGEN NV - Key news
Exhibits140: QIAGEN NV - Key offerings
Exhibits141: Thermo Fisher Scientific Inc. - Overview
Exhibits142: Thermo Fisher Scientific Inc. - Business segments
Exhibits143: Thermo Fisher Scientific Inc. - Key news
Exhibits144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits146: ZEKMED - Overview
Exhibits147: ZEKMED - Product / Service
Exhibits148: ZEKMED - Key offerings
Exhibits149: Inclusions checklist
Exhibits150: Exclusions checklist
Exhibits151: Currency conversion rates for US$
Exhibits152: Research methodology
Exhibits153: Validation techniques employed for market sizing
Exhibits154: Information sources
Exhibits155: List of abbreviations